SHG · Healthcare

BrightGene Bio Medical Technology C (688166)

Biotechnology

BrightGene Bio Medical Technology C (688166) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 688166

P/E ratio

25.00

BrightGene Bio Medical Technology C (688166) — FAQ

What is 688166's P/E ratio?

The price-to-earnings (P/E) ratio for BrightGene Bio Medical Technology C (688166) is 25.00 (data as of 2026-05-23).

Does BrightGene Bio Medical Technology C pay a dividend?

Dividend yield is not available in the current snapshot for BrightGene Bio Medical Technology C (688166). Check the MyAverix Finance app for the latest dividend data.

What sector is BrightGene Bio Medical Technology C in?

BrightGene Bio Medical Technology C (688166) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 688166 listed on?

688166 is listed on SHG.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)